D-mannose

Simple sugar that lowered recurrent UTIs versus placebo in a small meta-analysis of adult women; the comparison with antibiotics was inconclusive.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
Prevention: 2 g/day
Time to effect
Prevention effect assessed over 6 months
Safety
Has documented cautions

Evidence ratings summarise published research on D-mannose in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about D-mannose

Interactions

Taking any medication?

Check D-mannose against it.

Why

D-mannose is a simple monosaccharide that is absorbed and excreted unchanged in urine. A meta-analysis of three small studies (one RCT, one crossover trial, one cohort study) found fewer recurrent UTIs with D-mannose than placebo in adult women with recurrent infections (RR 0.23). Against preventive antibiotics the result was not statistically significant, with high heterogeneity. Side effects were infrequent, mainly diarrhoea. A German guideline allows it as an option in place of long-term antibiotics in some women, while NICE judged the evidence insufficient. D-mannose is not for treating an established UTI.

How it works

Binds the FimH lectin on Type-1 pili of uropathogenic E. coli (the cause of ~80% of UTIs), blocking adherence to bladder uroepithelium. Saturating urinary D-mannose levels coat the bacterial pili. Pathogen is then mechanically washed out with normal voiding.

Expected onset · Prevention effect assessed over 6 months

How to take

Dosage

Prevention: 2 g/day (e.g. one teaspoon of powder in water).

Timing

With water; spaced if multiple daily doses

On the label

'D-mannose' powder (most cost-effective) or capsules with stated grams per serving. Pharmaceutical-grade is preferred.

Studied in

Adult women with recurrent uncomplicated UTI, discussed with a clinician.

Safety

Not for treatment of an established UTI without medical evaluation. Fever, flank pain, blood in the urine or UTI symptoms in pregnancy need prompt medical care. D-mannose does not kill bacteria, only mechanically reduces adherence. Mild GI upset (bloating, soft stool) at higher doses. Mild glucose-equivalent calorie load. Note for strict glycaemic management. Pregnancy: limited data; coordinate with the prescribing clinician for recurrent UTI in pregnancy.
Loading interactions…

Evidence

At a glance

Lenger 2020 Am J Obstet Gynecol meta-analysis (3 studies): recurrent UTI was less frequent with D-mannose than placebo in adult women with recurrent infections (RR 0.23), but the comparison with antibiotics was inconclusive (RR 0.39, CI 0.12-1.25). The German AWMF guideline (2024) allows D-mannose as an option in premenopausal women; NICE NG112 found the evidence insufficient.

GRADE certainty: Low — rated by Healicus using the GRADE method

Questions people ask

Does D-mannose work?

Lenger 2020 Am J Obstet Gynecol meta-analysis (3 studies): recurrent UTI was less frequent with D-mannose than placebo in adult women with recurrent infections (RR 0.23), but the comparison with antibiotics was inconclusive (RR 0.39, CI 0.12-1.25). The German AWMF guideline (2024) allows D-mannose as an option in premenopausal women; NICE NG112 found the evidence insufficient. Certainty of the evidence: Low, rated by Healicus using the GRADE method.

How is D-mannose taken?

Prevention: 2 g/day (e.g. one teaspoon of powder in water). Timing: With water; spaced if multiple daily doses. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Not for treatment of an established UTI without medical evaluation. Fever, flank pain, blood in the urine or UTI symptoms in pregnancy need prompt medical care. D-mannose does not kill bacteria, only mechanically reduces adherence. Mild GI upset (bloating, soft stool) at higher doses. Mild glucose-equivalent calorie load. Note for strict glycaemic management. Pregnancy: limited data; coordinate with the prescribing clinician for recurrent UTI in pregnancy. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Lenger SM et al., D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis, Am J Obstet Gynecol 2020; AWMF guideline (2024): S3-Leitlinie Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen (HWI), AWMF 043-044; NICE guideline: Urinary tract infection (recurrent): antimicrobial prescribing (NG112).

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.